in accordance with the present invention , a method for treatment of inflammation is provided , which comprises administration of a therapeutically effective amount of the n - desulfated heparin . in the method of the present invention , the term “ therapeutically effective amount ” means the total amount of the n - desulfated heparin that is sufficient to show a meaningful patient benefit , that is , healing of pathological conditions characterized by leukocyte infiltration and deposition or increase in rate of healing of such conditions , whether administered in combination , serially or simultaneously . in practicing the method of treatment of this invention , a therapeutically effective amount of the n - desulfated heparin is administered to a mammal having a disease state . such disease states include inflammatory disorders such as various kinds of arthritis , asthma , dermatitis and psoriasis , acute respiratory distress syndrome , ulcerative colitis , various types of hepatitis , ischemia / reperfusion injury ( including myocardial , renal , skeletal muscular , intestinal , cerebral and pulmonary ischemia / reperfusion injury ), shock , severe trauma and transplant rejection . in practicing the method of the present invention , the n - desulfated heparin may be administrated alone or in combination with other therapies . for example , the non - anticoagulant heparin may optionally be used in combination with certain cytokines , lymphokines , or other hematopoietic factors such as m - csf , gm - csf , nksf , il - 1 , il - 2 , il - 3 , il - 4 , il - 5 , il - 6 , il - 7 , il - 8 , il - 9 , il - 10 , il - 11 , il - 12 , g - csf , meg - csf , and erythropoitin to treat inflammatory states . it is contemplated that the method of treatment will allow the non - anticoagulant heparin to synergize with the cytokine , lymphokine , or other hematopoietic factor , thereby augmenting the anti - inflammatory response . alternatively , the method of treatment will allow the n - desulfated heparin to minimize the potential side effects caused by the cytokine , lymphokine , or other hematopoietic factor . pharmaceutical compositions used to practice the method of the present invention may contain , in addition to the n - desulfated heparin , pharmaceutically acceptable carries , diluents , fillers , salts , buffers , stabilizers , and / or other materials well known in the art . the term “ pharmaceutically acceptable ” means a non - toxic material that does not interfere with the effectiveness of the biological activity of the active ingredient ( s ). the characteristics of the carrier or other material will depend on the route of administration . administration of the n - desulfated heparin used to practice the method of the present invention can be carried out in a variety of conventional ways , such as oral ingestion , or cutaneous , subcutaneous , or intravenous injection . intravenous administration to the patient is preferred . when a therapeutically effective amount of the n - desulfated heparin is administered orally , the non - anticoagulant heparin will be in the form of a tablet , capsule , powder , solution or elixir . when administrated in tablet form , the pharmaceutical composition of the invention may additionally contain a solid carrier such as a gelatin or an adjuvant . the tablet , capsule , and powder contain from about 5 to 95 % the n - desulfated heparin , and preferably from about 25 to 90 % the n - desulfated heparin . when administered in liquid form , a liquid carrier such as water , petroleum , oils and animal or plant origin such as peanut oil , mineral oil , soybean oil , or sesame oil , or synthetic oils may be added . the liquid form of the pharmaceutical composition may further contain physiological saline solution , dextrose or other saccharide solution , or glycols such as ethylene glycol , propylene glycol or polyethylene glycol . when administered in liquid form , the pharmaceutical composition contains from about 0 . 5 to 90 % by weight of the n - desulfated heparin , and preferably from about 1 to 50 % the n - desulfated heparin . when a therapeutically effective amount of the n - desulfated heparin is administered by intravenous , cutaneous or subcutaneous injection , the n - desulfated heparin will be in the form of a pyrogen - free , parentally acceptable protein solutions , having due regard to ph , isotonicity , stability , and the like , is within the skill in the art . a preferred pharmaceutical composition for intravenous , cutaneous , or subcutaneous injection should contain , in addition to the n - desulfated heparin , an isotonic vehicle such as sodium chloride injection , ringer injection , dextrose injection , dextrose and sodium chloride injection , lactated ringer injection , other vehicle as known in the art . the pharmaceutical composition used to practice the method of the present invention may also contain stabilizers , preservatives , buffers , antioxidants , or other additive known to those of skill in the art . the amount of the n - desulfated heparin in the pharmaceutical composition used to practice the method of the present invention will depend upon the nature and severity of the condition being treated , and on the nature of prior treatments which the patient has undergone . ultimately , the attending physician will decide the amount of the n - desulfated heparin with which to treat each individual patient . it is contemplated that the various pharmaceutical composition should contain about 0 . 1 μg to about 100 mg of the n - desulfated heparin per kg body weight . the duration of intravenous therapy using the pharmaceutical composition used to practice the method of the present invention will vary , depending on the severity of the disease being treated and the condition and potential idiosyncratic response of each individual patient . it is contemplated that the duration of each application of the n - desulfated heparin will be in the range of 12 to 24 hours of continuous intravenous administration . ultimately the attending physician will decide on the appropriate duration of intravenous therapy using the pharmaceutical composition of the present invention . the pharmacokinetics and the toxicity experiments of the n - desulfated heparin are being carried now . the sodium salt of heparin ( sigma ) was passed through a column of dowex ( strongly acidic cation exchanger 50 × 4 - 100 ; sigma ) and the effluent was neutralized with pyridine . it was then lyophilized to give a white powder [ inoue and nagasawa , carbohydr . res . 46 , 87 - 95 ( 1976 )]. the pyridine salt of heparin ( 100 mg dissolved in 0 . 25 ml of double destined and deionized h 2 o ) was mixed with 4 . 75 ml of dimethylsulfoxide ( dmso ; sigma ) at 50 ° c . for 2 hour ( sample no . 4 ), 1 hour ( sample no . 1 ), or 20 ° c . for 3 hours ( sample no . 3 ). the sample was diluted with an equal volume of h 2 o and the reaction was terminated by adjusting ph to 7 . 0 with 0 . 1 nnaoh [ nagasawa and inoue , carbohydr . res . 36 , 265 - 271 ( 1976 ); inoue and nagasawa , carbohydr . res . 46 , 87 - 95 ( 1976 ); tiozzo et al ., thromb . res . 70 , 99 - 106 ( 1993 )]. the sample no . 1 heparin was further dissolved in 1 nnaoh ( 4 % heparin concentration ) at 60 ° c . for 4 hours followed by neutralization to ph 7 . 0 with 1 n hcl ( sample no . 2 ). the pyridine salt of heparin was dissolved in 1 nnaoh ( 4 % heparin concentration ) followed by treatment at 40 ° c . ( sample no . 5 ) or at 60 ° c . ( sample no . 6 ) for 4 hours . further , the sodium salt of heparin was dissolved in 1 n naoh ( 4 % heparin concentration ) followed by treatment at 40 ° c . ( sample no . 7 ) or at 60 ° c . ( sample no . 8 ) for 4 hours . sample was then neutralized to ph 7 . 0 with 1 n hcl [ tiozzo et al ., thromb . res . 70 , 99 - 106 ( 1993 ); lloyd et al ., biochem . pharmacol . 20 , 637 - 648 ( 1971 )]. after chemical modification , these heparin derivatives were individually passed through a column of amberlite ira - 400 ( strongly basic anion exchanger ; sigma ) to remove the free sulfate ions . the effluent was neutralized to ph 7 . 0 with 1 n naoh . it was then desalted by passing through a column of bio - gel p - 2 ( bio - rad ). heparins were monitored at the optical densities of 214 nm and 230 nm . activated partial thromboplastin time ( aptt ) was measured using fresh human blood from healthy volunteers . the known amounts of heparin , low molecular weight heparin and the chemically modified heparin derivatives were added prior to the determination of aptt using silimat ™ ( biomeieux sa ) as activator . six assays were performed for each compound and the anticoagulant activity was expressed as the concentration ( ug / ml ) that doubles the aptt time ( 2 - aptt ). the higher concentration is parallel to the lower anticoagulant activity ( table 1 ). the same assay was carried to determine the aptt time of the mice in vivo ( fig4 .). solution and reagents : 5 % sodium nitrite , 33 % acetic acid , 3 . 8 % trichloroacetic acid , barium chloride - gelatin reagent ( prepared by dissolving 1 g of gelatin in 100 ml of water , incubated at 60 ° c . to make a complete dissolution , then put it at 4 ° c . overnight . the mixture was filtered after adding 0 . 5 g of barium chloride and was ready to use after standing for 4 hours at room temperature . this reagent was stored at 4 ° c . and could be used for about one week .) n - sulfates in heparin and various chemically modified heparin derivatives were determined by nitrous acid treatment as described [ inoue and nagasawa , anal . biochem . 71 , 46 - 52 ( 1976 )]. briefly , 0 . 5 ml of a sample solution was mixed with 0 . 5 ml of 5 % sodium nitrite and 0 . 5 ml of 33 % acetic acid . after shaking , the mixture was incubated at room temperature for 30 min and 4 . 5 ml of 3 . 8 % trichloroacetic acid was then added . after shaking again , 1 . 5 ml of the barium chloride - gelatin reagent was added . following shaking again immediately , the sample was left standing for 20 min and the turbidity of the sample was measured at 500 nm . the absolute n - sulfate mounts of all n - desulfated heparin sample were calculated with k 2 so 4 as control , while the relative n - sulfate mounts of all n - desulfated heparin were calculated using the starting heparin as 100 %. the contents of uronic acid of the no . 4 sample and heparin were determined according to the method of bitter and muir ( anal . biochem . 4 : 330 - 334 , 1962 ). the hexosamine contents were determined according to the method of elson and morgan ( biochem . j . 27 : 1824 - 1828 , 1993 ). the contents of free amino group , at a 2 mg / ml concentration , were determined as before ( yoshizawa et al ., biochim . biophys . acta ., 141 : 358 - 365 , 1967 ). reducing power , at a 2 mg / ml concentration , was measured using the 3 , 6 - dinitrophthalic acid method ( momose et al ., talanta , 4 : 33 - 37 , 1960 ). the average molecular weights were determined using the end group analysis ( hopwood and robinson , biochem . j . 135 : 631 - 637 , 1973 ). balb / c mice ( males , 5 weeks old , 20 ± 1 g body weight ) were purchased from shanghai animal center of chinese academy of sciences . negative control group contained 8 mice , they were intraperitoneally injected with 1 ml of sterile pyrogen - free saline . fifteen minutes later , mice were intravenously injected with 0 . 2 ml sterile pyrogen - free saline alone . the positive control group ( 12 mice ) was intraperitoneally injected with 1 ml of 3 % thioglycollate broth . fifteen minutes later , mice were intravenously injected with 0 . 2 ml saline . the mice of the anti - inflammation group ( 7 - 11 ) were intraperitoneally injected with 1 ml of 3 % thioglycollate broth . fifteen minutes later , mice were intravenously injected with saline containing 1 . 5 mg of low molecular weight heparin or any of the chemically modified heparin derivatives . mice were sacrificed at 2 hours . the peritoneal cavities were lavaged with 8 ml of ice - cold pbs containing 10 u / ml of heparin to prevent clotting . centrifuged at 1500 rpm for 5 mins . the total peritoneal leukocytes and their differentiation ( lymphocyte , monocyte and granulocyte ) were measured using cell - dyn1700 ( abbot laboratories , usa ). the mice of heparin therapeutic groups appear more active than the positive control group during the experiments time . shortly after the injection of the samples , few mounts of blood was bleeding from the pinpricks of the mice administrating the no . 4 sample , concomitantly the coagulant time was shorter than those groups administrating other heparin samples . furthermore , when collecting the total peritoneal infiltrated leukocytes , the group administrating no . 4 sample showed no inner bleeding phenomena , but other groups has little or more bleeding . the experiments watching above reflected the no . 4 sample has significant reduced anticoagulant activity while remaining the anti - inflammation effect . [ 0118 ] fig1 shows the result of the anti - inflammation screening assay in vivo , at the same time table 2 represents the inhibition percent of the peritoneal infiltrated inflammation leukocytes . 1 - ( cell   number   of   all   heparin   derivatives - cell   number   of   negative   control ) ( cell   number   of   positive   control - cell   number   of   negative   control ) all n - desulfated heparin has different anti - inflammation activity , the result showed that the total white blood cell inhibition percent is about 52 . 1 - 70 . 9 %, total lymphocyte inhibition percent is about 49 . 5 - 72 . 1 %, monocyte inhibition percent is about 47 . 6 - 82 %, granucyte inhibition is about 10 . 6 - 40 . 9 %, all n - desulfated heparin has better anti - inflammation activity than lmh which is commonly used in the art , besides , n0 . 4 sample is the best . swiss mice ( five weeks old , weigh 16 g ) were purchased from shanghai animal center of chinese academy of sciences . each group contained 9 - 11 mice . all the experiments were carried on under 25 ± 1 ° c ., because the bleeding time was varied according to environment temperature . bleeding times of mice were measured exactly as described previously ( dejana et al ., 1982 ). low molecular weight heparin and the chemically modified heparin derivatives ( all at 0 . 12 mg / mouse ; 7 . 5 μg / gram of body weight ) were injected into each swiss mouse 15 min prior to the tail cutting ( 2 mm from the tail tip ) with a razor blade . for determination of bleeding time , the amputated tail was sunk longitudinally in phosphate buffered saline , ph 7 . 4 , at 25 ° c . complete clotting was recorded after stopping the bleeding for 30 sec . and if the bleeding time was longer than 15 min , it was counted as 15 min . fig2 shows the result : at the condition of injection of 120 ug sample per mouse , no . 1 , no . 2 , no . 4 samples have significant shorter bleeding time than lmh , little longer that the saline group . the assay and the experiment condition were according to that of example 5 . the no . 4 sample and lmh were injected into the swiss mice with the mounts of 0 . 75 mg / kg , 2 . 5 mg / kg , 7 . 5 mg / kg and 22 . 5 mg / kg respectively to test the bleeding time . fig3 shows the result , with the administration mounts of lmh increasing , the bleeding time prolongs sharply , while the no . 4 group has no apparent prolonging . therefore , we can say : no . 4 sample has non - anticoagulant activity . effect of the no . 4 sample in the rabbit ischemia and reperfusion injury model ischemia and reperfusion injury assay . new zealand albino rabbits were purchased from shanghai animal center of chinese academy of sciences . each group contains 6 rabbits . general anesthesia was induced and maintained by peritoneal injection of pentobarbital sodium ( 45 mg / kg ). after subcutaneous injections of lidocaine at the bases of rabbit ears to block the supplemental local nerves , both ears were carefully amputated at their bases in sterile conditions under a surgical microscope . only the central artery , the central vein , and a small non - vascular cartilage bridge were left intact . the ear &# 39 ; s sensory nerves were transacted to render the ears in a permanently anesthetic condition and the ears were approximated to their bases with suture . a non - traumatic microvascular clip was then placed on the central artery of each ear to stop the blood flow for complete ischemia . after 6 h , the clip was removed and the ear was allowed to spontaneous reperfusion ( mihelcic et al ., 1994 ; lee et al ., 1995 ; han et al ., 1995 ). for the therapeutic intervention , one bolus of intravenous administration of saline alone , saline with heparin or the no . 4 sample was given at the beginning time of reperfusion ( removal of the microvascular clip ). measurements of tissue edema and necrosis . ear volume ( as a reflection of tissue edema ) was measured daily for seven continuous days following removal of the microvascular clip . ear volume was quantified by determination of the volume displacement after inserting the amputated portion of the ear ( to the level of the suture line ) into a fluid - filled vessel . tissue necrosis was assessed , in a double - blind manner , by the presence or absence of tissue necrosis ( defined as & gt ; 5 % skin sloughing of the total ear surface ) on day 7 ( han et al ., 1995 ). mycloperoxidase ( mpo ) assay . mpo activities were measured as previously described ( geng et al ., 1990 ; schierwagen et al ., 1990 ; mihelcic et al ., 1994 ). the ear tissues ( no skins ) were surgically taken 24 h after reperfusion . they were weighed and placed ( 0 . 5 g / ml ) in 50 mm potassium phosphate buffer , ph 6 . 0 , supplemented with 0 . 5 % hexadecyltrimethyl - ammonium bromide ( sigma ). they were subsequently homogenized by freeze - thaw three times and sonication twice . the mixtures were then centrifuged at 10 , 000 g for 10 min . the supernatants were heated at 60 ° c . for 2 h to inactivate potential inhibitors of mpo . for generation of standard curves , fresh blood was taken from healthy rabbits and rabbit neutrophils were isolated using ficoll - paque plus ( amersham pharmacia biotech ) according to the manufacturer &# 39 ; s instructions . these isolated neutrophils were more than 95 % pure based on differential staining of leukocytes . tissue histology . tissues were taken by the 3 - mm punch biopsy from the anesthetic ears 24 h after the operation . samples were fixed by immersion in bouin &# 39 ; s fixation solution ( 75 % picric acid , 24 % formaldehyde , 1 % acetic acid ) for 24 h at 24 ° c . followed by paraffin embedding . tissue sections ( 5 - μm thick ) were subsequently dewaxed and stained with hematoxylin and eosin . they were photographed at × 280 . 17 male piglets ( 6 . 0 - 7 . 4 kg body weight , average 6 . 7 kg ) were purchased from shanghai pasturage institute , shanghai academy of agricultural sciences ( saas ). the piglets were abrosiaed for 12 hours . before the operation the piglets were intramuscularly injected with prazosin ( 0 . 02 mg / kg ) and sedated with ketamine hydrochloride ( 7 mg / kg , made by shanghai middle west pharmaceutical co . ltd ). fifteen minutes later the piglets and the scarf skin for operation and intubation were cleaned . after the vein bypass established the piglets were given intravenous injection of with 2 . 5 mg / kg propofol ( fresenius , germany ) to induce anesthesia . the piglets were put on the infrared constant temperature table ( yqt - 2 , made by shanghai ) on their back . then 0 . 15 mg / kg vecuronium bromide ( made by china xianju pharmaceutical company , ltd .) was given ( i . v .) to relax the muscle . a ballonet catheter was inserted through the mouth and it was linked to a respiration machine ( siemens , 900c ). after conventional sterilization and laying sheets the right arteriae femoralis was separated . and 24g cannulas were left for artery blood sample collection . the femoral were linked to hemodynamics equipments , which could monitor the artery blood pressure and rhythm of heart . thirty minutes later all items indicating the basic condition were detected . the piglets were divided into three groups and were operated according to the method . after the operation anesthesia were stopped and the piglets came round naturally . the trachea cannulas were withdrawn when they could breath independently , pao 2 ( partial pressure of oxygen ) was lower than 40 mmhg , sao 2 ( oxygen saturation ) was higher than 95 percent and could react to pain stimulation . then the piglets were put in incubator where the temperature was maintained 21 centigrade . the piglets were intramuscularly injected with bucinnazine hydrochloride to ease pain and were given ( i . v .) glucose - lactate cycle solution ( 10 %, 5 ml / kg / h ). twenty - four hours later the piglets were induced anesthesia by intravenous injection and intubated into trachea again . the speed of injection was adjusted to 10 - 15 ml / kg / h according to heart rate , cvp ( central venous pressure ) and sap ( systemic arterial pressure ). after sterilization an incision was made in left femoral and a 24g cannula was inoculated for blood sample collection and hemodynamics monitoring . an incision was made in left venae jugulalis extema and an 18g catheter was left for cvp monitoring and venous blood sample collection . when the condition of the piglets was stable the right - down part on the abdomen was sterilized and laid sheet again . after different operations depending on different group the piglet belong the incision was closed . the piglets were given intravenous injection of gentamicin ( 20 , 000 units ) to prevent inflammation . when ali appeared the piglets were treated according to requirements of each group . sputum was suctioned every 2 hours during the experiment . 1 mg / kg propofol and 0 . 05 mg / kg vecuronium bromide were once injected discontinuously to maintain the breath frequency at 40 - 50 times per minute and v e at 0 . 3l / min / kg . the piglets were treated with 5 % nahco 3 solution in case acidosis emerged . when sap was lower than 60 mmhg , the piglets were given ( i . v .) dopamine to maintain the blood pressure . at the end of the experiment the piglets were sacrificed with 10 ml 10 % kcl solution ( i . v .). the piglets were divided into three groups at random before the experiment . group a ( control group , n = 5 ): the piglets were made an incision at the right - lower abdomen ( 3 cm ) and the intestine were agitated before the incision was closed . twenty - four hours later the incision was opened again and the intestine was agitated again . the incision was closed after the peritoneal cavity was washed with 200 ml saline ( 37c ). the animals were observed for 12 hours . group b ( model group , n = 6 ): an incision at the right - lower abdomen ( 3 cm ) was made followed by a 2 - cm perforation in the distal cecum ( 5 cm from the end ). it was sewed and 0 . 5 cm mucosa was evaginated in order to form an ostium with a diameter of 2 cm . the incision was then closured surgically . twenty - four hours later , the incision was opened again and the ostium was sewn up . the incision was eventually closured after washing the peritoneal cavity with 200 ml saline . ( 37 ° c .). the piglets were treated with machinery gassing after ali emergence . group c ( therapy group , n = 6 ): all procedures were exactly identical to group b except that 12 mg / kg no . 4 sample was intravenously administered in early phase of acute lung injury . a . pao 2 / fio 2 & lt ; 300 mmhg ( pao 2 : partial pressure of oxygen ; fio 2 : fraction inspired oxygen concentration ) b . pulmonary dynamics compliance ( cdyn ) is lower than that in basic condition by 30 %. perfusion fixation of lung : piglets were heparinized , the thorax was opened and the left and right main bronchia were separated . the left lung was inflated with air pressure of 30 cmh 2 o . one minute later some air was let out to keep the pressure at about 10 cmh 2 o . meanwhile the right ventricle and the left atria were opened and perfused with 4 % formalin at pressure of 65 cmh 2 o for 30 minutes . the left lung was kept in 4 % formalin . three days later lung tissue was taken at 0 , 2 , 6 and 9 point respectively in order to minimize the effect of gravity on the pathological change . tissue samples were subsequently dehydrated , embedded with paraffin , sliced up and stained with hematoxylin and eosin ( he ). tissue sections were observed with optical microscope and were classified into 5 grades according to edema , bleeding , infiltration of inflammation cell , pathological change coursed by epithelium injury of small air passage : 0 grade means normal ; 1 grade means that the pathological change is light and area limited ; 2 grade means that the pathological change is middling and limited ; 3 grade that the pathological change is middling but extensive or remarkable at some part ; 4 grade means that the pathological change is remarkable and extensive . the effects of no . 4 sample on the mouse model of acute liver injury hypersensitivity on swiss mice ( 18 - 22 g body weight ) were induced by smearing 1 % ( w / v ) pcl in absolute ethanol solution on abdomen after the ventral hair razed for 5 consecutive days . after another five days , 0 . 5 % pcl olive oil solution ( sigma chemical co . st . louis , mo .) was intrahepatically injected . blood samples were collected 18 hours for the measurements of alanine aminotransferase ( alt ). mice were intraperitoneal administered twice either saline , no . 4 sample ( 10 or 20 mg / kg ) or cyclophospamide ( 10 mg / kg ) at 0 and 5 hours after pcl intrahepatically injection . table 3 shows the results : the alt level of the positive control group is markedly increased compared with that of normal group . treatment with no . 4 ( both dosages ) or cyclophosphamide markedly deduced the alt level compared with positive control . human umbilical vein endothelial cells ( huvecs ; less than three passages ) were cultured on one - well chamber slide ( nalge nunc , naperville , ill .) pre - coated with 1 % gelatin as previously described ( geng et al ., 1990 ; asa et al ., 1995 ). for cytokine stimulation , monolayers of huvecs were incubated with 300 units / ml of tumor necrosis factor - α ( tnf - α ; promega , madison , wis .) for 12 h . slides were mounted in a flow chamber as before ( ma and geng , 2000 ). human promyeloid hl - 60 cells ( ccl 240 ) were purchased from american tissue culture collection ( rockville , md .). they were cultured in rpmi 1640 medium supplemented with 10 % heat inactivated newborn bovine calf serum ( bcs ), 4 mmol / l l - glutamine , 100 units / ml penicillin and 100 μg / ml streptomycin at 37 ° c . in the presence of 5 % co 2 . after washing once with pbs , hl - 60 cells were resuspended at 0 . 5 × 10 6 / ml in pbs supplemented with 10 mmol / l hepes , ph 7 . 4 , and 2 mmol / l cacl 2 in the presence of heparin , lmwh and the sample no . 4 at 22 ° c . for 15 min . they were then precisely injected through the flow chamber at 22 ° c . using a syringe pump . the wall shear stress used was 2 . 0 dyne / cm 2 . the numbers of bound cells were quantified from videotape recordings of 10 - 20 fields of view obtained ( 3 - 4 min after flowing cells through the chamber ). effect of the no . 4 sample on preventing the transmigration of human neutrophils through the monolayers of the stimulated huvecs huvecs ( 5 × 10 4 cells / well ) were seeded in the upper chambers of 24 - well transwell ® plates ( costar , cambridge , mass .) pre - coated with 1 % gelatin . for cytokine stimulation , monolayers of huvecs were incubated with 300 units / ml of tnf - α for 12 h ( geng et al ., 1997 ). fresh human blood was obtained from healthy volunteers according to the regulations of chinese academy of sciences . human neutrophils were isolated using ficoll - paque plus ( amersham pharmacia biotech , shanghai , china ) according to the manufacturer &# 39 ; s instructions . the isolated neutrophils were more than 95 % pure based on differential staining of leukocytes . after washing the upper chambers twice , human neutrophils ( 2 . 5 × 10 6 cells / ml ; more than 95 % purity ) were resuspended in serum - free m199 medium , in the presence of heparin , lmwh and the sample no . 4 , and added to the upper chambers of the transwell plates for 1 h . the upper wells were then removed and the cells sticking on the lower surface of the filters were released by repeated pipetting . cells in the lower chambers were counted using a hemocytometer .
the invention relates to the use of n - desulfated heparin for treating or preventing inflammation , which is based on the experimental results in animal acute abdominal inflammation model and animal bleed model . the n - desulfated heparin &# 39 ; s anti - inflammation activity is better than or equal to that of the low molecular weight heparin , and has low activity of anti - coagulant . from a series of n - desulfated heparin of different n - sulfur - containing , a sample of the best anti - inflammation activity and the lowest anti - coagulant activity was selected . the invention solved the problem of bleeding in the use of heparin for treating of inflammation , and provided a new pathway to use heparin to prevent and treat inflammation .